Yazaki wants a subzone in Petoskey—yawn, standard trade zone paperwork.

2026-20253, Foreign-Trade Zone (FTZ) 75; Authorization of Production Activity; Essai, Inc.; (Semiconductor Test Equipment); Chandler, Arizona

Essai, Inc. in Chandler, Arizona, got the green light to make semiconductor test equipment inside Foreign-Trade Zone 75. This means they can produce their high-tech gear with special trade benefits, helping them save money and speed up operations. The approval was finalized on September 28, 2026, so Essai can start or continue their work without any extra delays.

2026-20254, Foreign-Trade Zone (FTZ) 45; Authorization of Limited Production Activity; Qorvo US, Inc.; (Semiconductor Wafers and Modules); Hillsboro, Oregon

Qorvo US, Inc. in Hillsboro, Oregon got the green light to start limited production of semiconductor wafers and modules in Foreign-Trade Zone 45. This means they can use some imported parts with special rules for two years, helping them save money and speed up manufacturing. The approval came after a careful review and public input, so it’s official and ready to roll!

2026-20261, Foreign-Trade Zone (FTZ) 153; Authorization of Limited Production Activity; CMS Circuits, Inc.; (Electronic Manufacturing Services in Aerospace, Industrial, and Medical Applications); Murrieta, California

CMS Circuits, Inc. in Murrieta, California, got the green light to start limited production of electronic parts for aerospace, industrial, and medical uses inside Foreign-Trade Zone 153. This means they can bring in certain fiber optic bundles under special foreign status, but only for two years. The City of San Diego and local businesses will benefit from this move, which could boost local manufacturing and trade.

2026-19777, Foreign-Trade Zone (FTZ) 106, Notification of Proposed Production Activity; Hitachi Vantara Manufacturing; (Enterprise Datacenter Disk Storage System Hardware); Norman, Oklahoma

Hitachi Vantara Manufacturing in Norman, Oklahoma, wants to start making parts for datacenter disk storage systems inside Foreign-Trade Zone 106. This means they can use some imported materials with lower or no import taxes, helping them save money and speed up production. The government got their request on September 16, 2026, and is reviewing it now.

2026-19699, Foreign-Trade Zone (FTZ) 57, Notification of Proposed Production Activity; Eli Lilly and Company; (Drug Products); Concord, North Carolina

Eli Lilly wants to start making several important drug products at their Concord, North Carolina facility under special Foreign-Trade Zone rules. This move helps them save on import duties for certain materials while producing medicines for diabetes, migraines, inflammation, weight management, and Alzheimer's. The government got their request on September 17, 2026, and is reviewing it to give the green light soon.

2026-19698, Foreign-Trade Zone (FTZ) 93, Notification of Proposed Production Activity; Eli Lilly and Company; (Drug Products); Durham, North Carolina

Eli Lilly wants to start making several special drug products at their Durham, North Carolina facility under Foreign-Trade Zone 93. This means they can use certain imported materials without paying duties while producing medicines for diabetes, migraines, inflammation, weight management, and Alzheimer's. The change could speed up production and save money, with the proposal officially received on September 17, 2026.

Previous: 2026-16835, Columbia Gas Transmission, LLC; Notice of Request Under Blanket Authorization and Establishing Intervention and Protest Deadline

Columbia Gas Transmission wants to retire about 5.58 miles of old pipeline and remove some equipment in Kentucky and West Virginia. This cleanup will help a nearby company grow since Columbia no longer needs these pipes for its gas service. The project costs nearly $2.8 million, and folks have until a set deadline to speak up or object.

Next: 2026-16837, Determining Whether To Submit an ANDA or a 505(b)(2) Application; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry titled "Determining Whether to Submit an ANDA or a 505(b)(2) Application." This draft guidance is intended to serve as a foundational guidance to assist applicants in determining which one of the abbreviated approval pathways under the Federal Food, Drug, and Cosmetic Act (FD&C Act) is appropriate for the submission of a marketing application to FDA. This draft guidance revises the guidance for industry titled "Determining Whether to Submit an ANDA or a 505(b)(2) Application" issued in May 2019 and, when finalized, will replace the 2019 guidance for industry.